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Abstract: The interaction between cells and biopolymers is the evaluation indicator of the 
biocompatibility of materials. The purpose of this work was to examine the responses of 
retinal  pigment  epithelial  (RPE)  cells  to  genipin  (GP)  or  glutaraldehyde  (GTA)  
cross-linked chitosan by means of cell viability assays, cytokine expression analyses, and 
apoptosis assays. Evaluations of non-cross-linked chitosan were conducted simultaneously 
for comparison. Both GP and GTA treated samples with the same extent of cross-linking 
(around 80%) were prepared by varying cross-linking time. Our results showed that GP 
cross-linking was carried out by either radical polymerization of the monomers or SN2 
nucleophilic  substitution  reaction  involving  the  replacement  of  the  ester  group  on  the 
monomer with a secondary amide linkage. On the other hand, GTA could react with free 
amino  groups  of  chitosan,  leading  to  the  formation  of  either  the  Schiff  bases  or  the 
Michael-type adducts with terminal aldehydes. The biocompatibility of non-cross-linked 
chitosan  membranes  was  demonstrated  by  the  absence  of  any  signs  of  toxicity  or 
inflammation reaction. The present study showed that the ARPE-19 cells exposed to GTA 
cross-linked chitosan membranes had significantly higher cytotoxicity, interleukin-6 levels, 
and number of TUNEL-positive nuclei than did those exposed to GP treated samples. In 
addition, the materials modified with GTA trigger apoptosis at an early stage and may 
induce  toxicity  in  the  RPE  cells  later.  The  findings  suggest  that  while  the  chitosan 
molecules bridged by GP are satisfactorily cytocompatible, the counterparts treated by GTA 
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do not seem to be tolerated. In terms of material safety, the GP cross-linked chitosan may 
be compatible with human RPE cells and may have a potential application as delivery 
carriers in the treatment of posterior segment diseases. 
Keywords:  chitosan;  cross-linking;  genipin;  glutaraldehyde;  cytocompatibility;  retinal 
pigment epithelial cells 
 
1. Introduction 
Age-related macular degeneration (AMD) is a clinical entity well known in people 50 years of age 
or  older  in  the  developed  world  [1].  Retinal  transplantation  has  been  investigated  as  a  possible 
therapeutic strategy for repair of damaged tissues in such degenerative conditions [2–4]. However, the 
limited availability of donor retinas is a major barrier in transplantation medicine. Currently, other 
techniques such as pharmacologic therapy and gene therapy are being studied to treat AMD. In 2005, 
Kataoka et al. [5] developed a polyion complex micelle that can be used as a novel delivery carrier for 
dendrimer  porphyrin.  The  highly  selective  accumulation  of  the  micelle-encapsulated  dendrimer 
porphyrin  into  choroidal  neovascularization  lesions  may  result  in  a  significantly  pronounced 
photodynamic  effect  with  minimal  unfavorable  phototoxicity.  Their  group  also  presents  a  ternary 
complex system composed of a core containing DNA packaged with cationic peptides and enveloped 
in  the  anionic  dendrimer  phthalocyanine,  which  exhibits  more  than  100-fold  photochemical 
enhancement of transgene expression in vitro with reduced photocytotoxicity [6]. These studies suggest 
that  by  means  of  electrostatic  interaction  with  oppositely  charged  carrier  materials,  the  negatively 
charged drug or DNA can stably be incorporated into the nanocarrier for more effective delivery. 
Chitosan  is  a  naturally  occurring  cationic  polysaccharide  obtained  by  deacetylation  of  chitin,  a 
biopolymer second in abundance to cellulose. It is primarily comprised of repeating  D-glucosamine 
units and shows antibacterial and wound healing activities [7,8]. As a biomaterial, chitosan has good 
biocompatibility [9,10]. In the field  of ophthalmology, chitosan has  been of great interest in drug 
delivery applications. The mucoadhesiveness of chitosan makes it an attractive carrier for increasing 
corneal residence time and enhancing bioavailability by interacting with the negative charges of the 
mucus [11]. A recent review by Alonso et al. [12] has provided a detailed description of the potential 
of chitosan-based nanosystems for topical ocular administration. Despite numerous studies supporting 
the  benefits  of  chitosan  in  delivering  drugs  onto  the  eye  surface,  very  limited  experience  on  the 
intraocular use of chitosan carriers has been reported [12]. 
Cross-linking is recommended to overcome the hydrophilic nature of chitosan for its application as 
a drug carrier [9]. Water-soluble carbodiimides are considered as non-toxic cross-linkers because they 
can be found as by-products of the reaction, in the form of urea derivatives [13]. In our laboratory, 
carbodiimides have been successfully applied for cross-linking of biopolymers such as gelatin [4,14] 
and  hyaluronic  acid  [15,16]  to  fabricate  cell/tissue  delivery  carriers.  Since,  in  essence,  chitosan 
materials  carry  free  amine  functionalities  and  lack  free  carboxylic  acid  groups  available  for 
carbodiimide cross-linking, other agents, i.e., genipin (GP) and glutaraldehyde (GTA) are more feasible 
for chemical modification. It is known that although cross-linking is a common method to increase the Int. J. Mol. Sci. 2010, 11                       
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stability of biomaterials, the treatment involving the use of chemical cross-linkers probably causes 
toxic side-effects [17]. Several studies have evaluated the compatibility of GP or GTA cross-linked 
chitosan-based  materials  towards  HeLa  cells  [18],  human  foreskin  fibroblasts  [19],  L929  murine 
fibroblasts  [20],  Caco-2  cells  [21],  and  pig  iliac  endothelial  cells  [22].  However,  the  previous 
documents do not have the focus on the ocular biocompatibility of chemically modified chitosan. 
In view of the potential of the development of cross-linked chitosan-based drug delivery systems for 
the treatment of posterior segment diseases such as AMD, diabetic retinopathy, and cytomegalovirus 
retinitis, there must be concern about the possible safety issues related to chemical cross-linking of 
biomaterials.  Here,  we  performed  an  in  vitro  study  to  examine  the  responses  of  retinal  pigment 
epithelial (RPE) cells to GP or GTA treated chitosan. Evaluations of non-cross-linked chitosan samples 
were conducted simultaneously for comparison. The information from cell-material interactions that is 
relevant  to  ocular  biocompatibility  will  facilitate  the  engineering  of  the  appropriate  cross-linked 
chitosan to enhance the delivery of drug therapeutics. 
2. Results and Discussion 
2.1. Preparation of GP or GTA Cross-Linked Chitosan Membranes 
In  this  study,  to  cross-link  the  chitosan  materials,  we  adopted  a  film  immersion  method  as 
previously  described  for  the  chemical  modification  of  gelatin  sheets  [23]  and  human  amniotic 
membranes [13]. The general reaction mechanisms for the GP and GTA cross-linking of chitosan are 
presented in Figure 1A and B, respectively. The formation of GP-amino group monomer is achieved by 
nucleophilic attack of free amino groups of chitosan on the third carbon of GP. Then, cross-linking is 
carried out by either radical polymerization of the monomers or SN2 nucleophilic substitution reaction 
involving the replacement of the ester group on the monomer with a secondary amide linkage. The 
detailed  reaction  pathways  for  GP  cross-linking  of  amino  group  containing  biopolymers  has  been 
discussed by Butler and colleagues [24]. On the other hand, GTA can react with free amino groups of 
chitosan,  leading  to  the  formation  of  either  the  Schiff  bases  or  the  Michael-type  adducts  with  
terminal aldehydes. 
The ninhydrin assay has been shown to be applicable for determining the extent of cross-linking in 
amino group containing biomaterials [4,13]. In this study, the cross-linking index of GP and GTA 
treated chitosan membranes was investigated as a function of cross-linking time (Figure 2). For GP-chi 
groups, the cross-linking degree significantly increased with increasing reaction time from 1 to 24 h  
(p < 0.05). A similar trend was found for the GTA-chi groups. At each time point, the cross-linking 
index of chitosan samples treated with GTA was significantly higher than their counterparts with GP  
(p  <  0.05),  which  indicated  that  the  GTA  demonstrates  a  higher  reactivity  during  chemical  
cross-linking. These findings are in accordance with previous results showing that the GTA produces 
stronger  cross-linking  to  gelatin  molecules  than  using  GP  [25].  It  is  known  that  the  cross-linker 
concentration, pH, temperature, and time greatly affect the cross-linking degree of biomaterials [26], 
which may further determine their compatibility with cells and tissues. Here, the chitosan membranes 
were modified with 10 mM of either GP or GTA at 25 °C , pH 7.4 for different time periods (0–24 h). 
To examine the influence of chemical cross-linkers on the biocompatibility of chitosan materials, the Int. J. Mol. Sci. 2010, 11                       
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GP and GTA treated samples with the same extent of cross-linking (i.e., 78.5 ±  2.8% for GP-chi at 8 h 
and 76.8 ±  2.6% for GTA-chi at 3 h) were characterized by various in vitro assays. 
Figure  1.  Cross-linking  reaction  scheme  of  chitosan  with  (A)  genipin  (GP),  and  
(B) glutaraldehyde (GTA). 
 
Before cytocompatibility tests, both above-mentioned samples with the same cross-linking degree 
were  studied  by  Attenuated  total  reflection-Fourier  transform  infrared  (ATR-FTIR)  spectroscopy, 
which  is  a  useful  tool  for  the  identification  of  molecular  interactions  in  the  chemically  modified 
biomaterials [13]. In this paper, it is difficult to interpret the spectra, primarily due to the large extent 
of  hydrogen  bonding  in  chitosan.  Therefore,  representative  spectra  for  various  membranes  in  the 
wavenumber range of 1900–1100 cm
−1 are shown in Figure 3. For Chi groups, the samples had several 
absorption bands at 1641 cm
−1 (C=O stretching in amide I), 1550 cm
−1 (N-H bending in amide II),  
1585 cm
−1 (N-H bending in non-acetylated 2-aminoglucose primary amine), and 1151 cm
−1 (C-O-C 
asymmetric stretching), which are characteristic of chitosan polysaccharide structure [27]. After GP 
cross-linking, the membranes revealed additional peaks at 1295, 1440, and 1630 cm
−1, which were 
assigned to the C-O-C asymmetric stretching and the CH3 bending of the methyl ester, and C=C ring 
stretching,  respectively.  These  data  are  in  agreement  with  previous  FTIR  study  on  GP  treated Int. J. Mol. Sci. 2010, 11                       
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biopolymers [28]. The spectra of the GTA-chi groups exhibited absorption at 1652 cm
−1, indicating the 
presence of C=N bonds from the Schiff bases. Furthermore, a new peak appeared at 1729 cm
−1 which, 
according to the literature [29], corresponded to the carbonyl groups in the Michael-type adducts. 
Figure 2. Cross-linking index of GP and GTA treated chitosan membranes as a function of 
cross-linking time. An asterisk  indicates statistically significant  differences  (*p < 0.05;  
n = 5) for the mean value of cross-linking index compared with the value at the previous 
time point. 
 
Figure 3. ATR-FTIR spectra of various chitosan membranes. 
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2.2. Cell Viability Assays 
Figure 4 shows representative photographs of ARPE-19 cells labeled with Live/Dead stain, where 
the live cells fluoresce green and the dead cells fluoresce red. Similar to our previous study [30], the 
cultures from the control groups maintain good viability (data not shown). A large percentage of live 
cells  was  also  observed  in  the  Chi  and  GP-chi  groups  (Figure  4A–D),  which indicates that these 
chitosan samples had good cytocompatibility. However, in the GTA-chi groups, the cultures contained 
a large number of dead cells (Figure 4E and F). Quantitative analysis of cell viability was performed 
following the Live/Dead assay, and the results are shown in Figure 5. The mean percentage of live cells 
did not show a significant difference between the control, Chi, and GP-chi groups (p > 0.05) after  
three days in culture. In addition, the viability of these RPE cell lines was greater than 96%. In contrast, 
the mean percentage of live cells was significantly reduced by about 86% (p < 0.05) for GTA-chi as 
compared to those of the control groups. The ARPE-19 cells exposed to GTA cross-linked chitosan 
membranes had relatively higher cytotoxicity than did those to GP treated samples. 
Figure 4. Cell viability of ARPE-19 cultures was determined by staining with Live/Dead 
Viability/Cytotoxicity  Kit  in  which  the  live  cells  fluoresce  green  and  the  dead  cells 
fluoresce  red.  Green  (A,  C,  E)  and  red  (B,  D,  F)  fluorescence  images  of  cells  after 
exposure to 5 mg of different types of chitosan membranes (A, B) Chi, (C, D) GP-chi, and 
(E, F) GTA-chi for 3 days at 37 °C . Scale bars indicate 100 μm. 
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Figure  5.  Mean  percentage  of  live  cells  in  the  ARPE-19  cultures  exposed  to  various 
chitosan membranes (5 mg) as measured by the Live/Dead assay. An asterisk indicates 
statistically significant differences (*p < 0.05; n = 3) as compared to controls (without 
materials). 
 
Chitosan is a well-known biocompatible and bioactive material and has been under investigation for 
a  vast  array  of  biomedical  applications  including  sutures,  wound  dressings,  tissue  engineering 
scaffolds, and drug/gene delivery vehicles [31]. Several reports have demonstrated the biocompatibility 
of chitosan by using various in vitro and in vivo assays [32,33]. The present study, based on cell 
viability data, provides evidence to support these earlier findings. Although chitosan membrane has no 
toxic  effects  on  RPE  cells  in  vitro,  chemical  cross-linking  may  induce  cell/tissue  responses  to 
biomaterials. As shown in the literature, GTA has been used to modify different biopolymers such as 
gelatin  [4],  hyaluronic  acid  [16],  and  chitosan  [19]  for  creating  intermolecular  covalent  bonds. 
However, GTA cross-linking is associated with cytotoxicity, which may be due to the specific linkages 
present in the cross-linking structure [4,16]. In this paper, GTA may react with free amino groups of 
biomaterials to form Michael-type adducts with terminal aldehydes, thereby causing harmful irritation 
to  cultured  cells.  On  the  contrary,  the  chitosan  molecules  bridged  by  GP  are  well  tolerated  with 
negligible  toxicity.  Mi  et  al.  [19]  have  reported  that  the  human  foreskin  fibroblasts  grow  with  a 
significantly  higher  viability  on  GP  cross-linked  chitosan  films  versus  GTA  treated  counterparts. 
Consistent with these data, we showed that the chitosan materials cross-linked with GP, in contrast to 
those  with  GTA,  are  more  compatible  toward human RPE cells  and have potential suitability for 
application as drug carriers in the treatment of posterior segment diseases. 
2.3. Pro-Inflammatory Gene and Cytokine Expression Analyses 
IL-6, which appears to be a major cytokine-triggering mediator in the later part of the acute phase, 
can  be  used  as  an  indicator  of  biocompatibility  of  the  materials  tested  [34].  For  evaluation  of 
inflammatory  responses  to  cross-linked  chitosan  membranes,  we  utilized  real-time  RT-PCR  and Int. J. Mol. Sci. 2010, 11                       
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ELISA to quantify the IL-6 expression at both the mRNA and protein levels. As shown in Figure 6, the 
pro-inflammatory gene expression of ARPE-19 cells after three days of exposure to biomaterials from 
the Chi, GP-chi, and GTA-chi groups was 117.4 ±  9.5, 113.8 ±  10.2, 860.3 ±  17.9%, respectively. A 
significant up-regulation of IL-6 mRNA expression was observed in the GTA-chi groups compared 
with the other groups (p < 0.05). On the other hand, Figure 7 shows the ARPE-19 cell secretion of  
IL-6 in response to various chitosan samples. The measured concentration of IL-6 in the GTA-chi 
groups  was  1161.7  ±   34.4  pg/mL,  which  was  significantly  higher  than  those  in  the  control  
(204.8 ±  27.2 pg/mL), Chi (229.3 ±  21.6 pg/mL), and GP-chi (190.5 ±  18.1 pg/mL) groups (p < 0.05). 
Figure  6.  Gene  expression  of  IL-6  in  ARPE-19  cells  incubated  with  various  chitosan 
membranes (5 mg) for 3 days, measured by real-time RT-PCR. Normalization was done 
using GAPDH. Data in the experimental groups are percentages relative to that of control 
groups  (without  materials).  An  asterisk  indicates  statistically  significant  differences  
(*p < 0.05; n = 3) as compared to controls. 
 
Chatelet  et  al.  [35]  have  reported  that  the  chitosan-based  biomaterials  do  not  show  any 
inflammatory or allergic reaction following implantation, injection, topical application or ingestion in 
the human body. Later studies from Mi et al. [9] and VandeVord et al. [32] also demonstrated that the 
tissue near the implantation site revealed little pathological inflammatory responses to intramuscular 
chitosan microspheres and intraperitoneal/subcutaneous chitosan scaffolds. The results of the present 
study on the degrees in inflammatory reaction confirm the in vitro ocular biocompatibility of chitosan 
materials. However, our data also show that the GTA cross-linked chitosan membranes have a marked 
stimulatory  influence  on  IL-6  production.  More  recently,  we  investigated  the  pro-inflammatory 
cytokine expression elicited in ARPE-19 cells in response to GTA cross-linked gelatin hydrogels and 
found similar effects [4]. The treatment of these samples with glycine following chemical modification 
may partially decrease cytotoxicity and inhibit inflammation, implying the role of aldehyde groups of 
the cross-linker on the interaction with  RPE cells.  In  contrast,  the ARPE-19 cells  exposed to  GP  
cross-linked  chitosan  materials  demonstrated  slightly  lower  levels  of  IL-6  than  did  those  to  Int. J. Mol. Sci. 2010, 11                       
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non-cross-linked counterparts, although these differences were not significant (p > 0.05). It is known 
that GP is a naturally occurring cross-linker and has been widely applied in herbal medicine and food 
industry [26]. Koo et al. [36] have reported that the GP possesses anti-inflammatory activities and is a 
specific  hydroxyl  radical  scavenger.  This  may  explain  our  results  showing  that  GP  cross-linked 
chitosan materials caused minimal cellular inflammatory reaction. 
Figure 7. Level of IL-6 released from ARPE-19 cell cultures after incubation with various 
chitosan  membranes  (5  mg)  for  3  days.  An  asterisk  indicates  statistically  significant 
differences (*p < 0.05; n = 4) as compared to controls (without materials). 
 
2.4. Apoptosis Assays 
Figure  8  shows  TUNEL  analysis  of  the  ARPE-19  cells  after  exposure  to  various  chitosan 
membranes  for  24  h.  While  TUNEL-positive  cells  were  observed  in  the  DNase-treated  cultures 
(positive controls), no apoptotic activity was detectable in the negative controls (data not shown). 
Representative fluorescence microscopic images of the control, Chi and GP-chi groups demonstrated 
total cell nuclei stained with DAPI in blue (Figure 8A–C). In contrast, numerous TUNEL-labeled cells 
with  fragmented  DNA  (green)  could  be  visualized  within  the  cultures  from  the  GTA-chi  groups 
(Figure 8D). The apoptotic index determined by TUNEL assay is shown in Figure 9. There was no 
statistically significant difference in the apoptotic index between the control, Chi, and GP-chi groups  
(p > 0.05). In the case of Chi and GP-chi groups, only approximately 1% of the cells were positively 
labeled with TUNEL. These results indicate that the non-cross-linked and GP cross-linked chitosan 
materials do not cause apoptosis in RPE cells. The proportion of apoptotic cells was significantly 
higher in cultures treated with GTA cross-linked chitosan membranes compared with those exposed to 
GP cross-linked samples (p < 0.05), suggesting that cross-linking of biomaterials with GTA may be 
relevant for apoptosis induction. Int. J. Mol. Sci. 2010, 11                       
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Figure  8.  Apoptotic  cells  labeled  with  TUNEL  assay  in  the  ARPE-19  cultures. 
Fluorescence micrographs of control cells (without materials) (A), and cells after exposure 
to  5  mg  of  different  types  of  chitosan  membranes  (B)  Chi,  (C)  GP-chi,  and  
(D)  GTA-chi  for  24  h  at  37  °C .  Blue  fluorescence  is  DAPI  nuclei  staining.  Green 
fluorescence is TUNEL-positive nuclei staining. Scale bars indicate 30 μm. 
 
Figure  9.  Apoptotic  index  of  ARPE-19  cells  exposed  to  various  indicated  chitosan 
membranes (5 mg) as determined by the TUNEL assay. An asterisk indicates statistically 
significant differences (*p < 0.05; n = 3) as compared to controls (without materials). 
 
Our  group  recently  developed  an  intraocular  cell  delivery  system  using  biopolymer-based  
carriers  [15,16,37–39].  Since  biocompatibility  is  a  prerequisite  for  this  carrier implant, an  in  vivo Int. J. Mol. Sci. 2010, 11                       
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animal model was previously established to assess the inflammatory response of the eye to biomaterials 
[40]. Here, we investigated the in vitro cellular responses to various chitosan materials using ARPE-19 
cultures  before  further  in  vivo  animal  experiments.  The  results  of  both  cell  viability  assays  and  
pro-inflammatory gene and cytokine expression analyses indicate that the GP cross-linked chitosan 
membranes  have  good  compatibility  towards  human  RPE  cells.  On  the  contrary,  the  samples  
cross-linked with GTA show cytotoxicity and are not suitable for intraocular application. It has been 
reported that cross-linker toxicity to osteoblasts cultured on GTA treated collagen/poly(vinyl alcohol) 
films is by the mechanism of apoptosis [41]. In accordance with these earlier observations, our data 
imply that the programmed cell death may be caused by the interaction of the exposed aldehyde groups 
with the surface of ARPE-19 cells. A recent study from Marczak et al. [42] also demonstrated that 
GTA would produce significant perturbations in the organization of plasma membrane lipids in human 
erythrocytes,  thereby  leading  to  conformational  alterations  in  membrane  cytoskeletal  proteins  and 
apoptosis  (self  destruction)  of  the  cells.  In  this  work,  the  GTA  cross-linked  chitosan  materials 
triggered-apoptosis at an early stage may induce toxicity in the RPE cells later. 
3. Experimental Section 
3.1. Materials 
Chitosan (Cat. No. 50494), derived from crab shell, was a commercial powder supplied by Fluka 
(Milwaukee, WI, U.S.). According to information from the manufacturer, the chitosan samples used as 
raw materials  had a degree of deacetylation  of 95–98% and a molecular weight of approximately  
150 kDa. Glutaraldehyde and ninhydrin reagent were purchased from Sigma-Aldrich (St. Louis, MO, 
U.S.).  Genipin  was  purchased  from  Wako  Pure  Chemical  Industries  (Osaka,  Japan).  
Phosphate-buffered  saline  (PBS,  pH  7.4)  was  obtained  from  Biochrom  AG  (Berlin,  Germany). 
Dulbecco’s modified Eagle’s medium/Ham’s F12 nutrient mixture (DMEM/F12) and TRIzol reagent 
were  purchased  from  Gibco-BRL  (Grand  Island,  NY,  U.S.).  Fetal  bovine  serum  (FBS)  and  the 
antibiotic/antimycotic (A/A) solution (10,000 U/mL penicillin, 10 mg/mL streptomycin and 25 μg/mL 
amphotericin B) were obtained from Biological Industries (Kibbutz Beit Haemek, Israel). All the other 
chemicals were of reagent grade and used as received without further purification. 
3.2. Preparation of GP or GTA Cross-Linked Chitosan Membranes 
The chitosan membranes (Chi group) were prepared by solution casting method. In brief, chitosan  
(1 g) was added to 1% v/v aqueous acetic acid (50 mL) with stirring until complete dissolution. To 
remove  insoluble  substance,  the  solution  was  passed  through  a  filter  paper  (Tokyo Roshi Kaisha, 
Tokyo, Japan). Then, 0.5 mL of chitosan solution was poured in a well of a 24-well plate (Falcon, 
Becton Dickinson Labware, Franklin Lakes, NJ, U.S.) and air-dried for 2 days at 25 °C  to obtain 
membranes (about 10 μm thick). The membrane samples were incubated in a 0.5 N NaOH solution for 
1 h and washed extensively with deionized water until neutrality. 
The  chitosan  materials  were  treated  with  GP  (GP-chi  group)  or  GTA  (GTA-chi  group)  by 
respectively immersing the membrane samples in 5 mL of PBS containing 10 mM cross-linker. The 
cross-linking  reaction  was  allowed  to  proceed  at  25  °C   for  different  time  periods  (0–24  h).  To Int. J. Mol. Sci. 2010, 11                       
 
 
5267 
eliminate the residual GP or GTA, the cross-linked membranes were washed extensively in deionized 
water. Then, the samples were dried in vacuo for 24 h and sterilized in a graded series of ethanol 
solutions and thoroughly rinsed in sterilized PBS for use in the in vitro experiments. 
The amount of free amino groups of chitosan membranes was determined to evaluate their extent of 
cross-linking [4]. The test sample was weighed and heated with a ninhydrin solution for 20 min. After 
the test solution was cooled to room temperature and diluted in 95% ethanol, the optical absorbance of 
the solution was recorded with a UV-visible spectrophotometer (Thermo Scientific, Waltham, MA, 
U.S.) at 570 nm using glycine at various known concentrations as standard. The amount of free amino 
groups in the chitosan materials before (Cb) and after (Ca) cross-linking is proportional to the optical 
absorbance of the solution. The extent of cross-linking of the chitosan membranes was calculated as 
cross-linking index (%) = ((Cb − Ca)/Cb) ×  100. Results were averaged on five independent runs. 
The FTIR spectroscopy of various chitosan membranes was performed using a FT-730 ATR-FTIR 
Spectrophotometer (Horiba, Japan) according to the previously published method [13]. The spectra 
were recorded between 1900 and 1100 cm
−1 with a resolution of 4 cm
−1. 
3.3. Human RPE Cell Line Cultures 
ARPE-19  cells,  a  spontaneously  immortalized  human  cell  line  (BCRC  No.  60383)  with 
morphological and functional characteristics similar to adult human RPE [30], were purchased from 
the Bioresource Collection and Research Center (Hsinchu, Taiwan, ROC). The cells were maintained 
in regular growth medium containing DMEM/F12, 10% FBS, and 1% A/A solution. Cultures were 
incubated in a humidified atmosphere of 5% CO2 at 37 °C . The cells from passage 38 were used for 
experiments. 
For  evaluation  of  cellular  responses  to  cross-linked  chitosan  materials,  an  indirect  contact 
methodology was used as described elsewhere [34]. In brief, ARPE-19 cells (7 ×  10
4 cells/well) were 
seeded in 24-well plates and maintained at 37 °C  with 5% CO2. Using cell culture inserts (Falcon 3095, 
Becton Dickinson Labware, Franklin Lakes, NJ, U.S.), each well of a 24-well plate was divided into 
two compartments. A 1-cm
2 membrane sample (5 mg) was then placed into the inner well of the 
double-chamber system to examine the cells cultured on the plastic plate. At specific time intervals, the 
qualitative  and  quantitative  assays  were  performed  following  removal  of  the  inserts  and  chitosan 
samples. ARPE-19 cells in regular growth medium without test materials served as control groups. 
3.4. Cell Viability Assays 
ARPE-19 cells were grown to confluence and then were exposed to various chitosan membranes for 
3 days. Cell viability was determined using the Live/Dead Viability/Cytotoxicity Kit from Molecular 
Probes (Eugene, OR, U.S.) [43]. This assay uses intracellular esterase activity to identify the living 
cells;  the  process  cleaves  the  calcein  acetoxymethyl  to  produce  a  green  fluorescence.  Ethidium 
homodimer-1 can easily pass through the damaged cell membranes of dead cells to bind to the nucleic 
acids, yielding a red fluorescence. After washing three times with PBS, the cultures were stained with a 
working solution consisting of 2 μL of ethidium homodimer-1, 1 mL of PBS, and 0.5 μL of calcein 
acetoxymethyl. By fluorescence microscopy (Axiovert 200M; Carl Zeiss, Oberkochen, Germany), three 
different  areas  each  containing  approximately  500  cells  were  counted  at  100×   magnification.  All Int. J. Mol. Sci. 2010, 11                       
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experiments were performed in triplicate, and the viability of the ARPE-19 cell cultures was expressed 
as the average ratio of live cells to the total number of cells in these nine different areas. 
3.5. Pro-Inflammatory Gene and Cytokine Expression Analyses 
ARPE-19 cells were grown to confluence and then were exposed to various chitosan membranes for 
3 days. Interleukin-6 (IL-6) expression was detected at both messenger RNA (mRNA) and protein 
levels  [30].  Total  RNA  was  isolated  from  ARPE-19  cells  with  TRIzol  reagent  according  to  the 
manufacturer’s  procedure.  Reverse  transcription  of  the  extracted  RNA  (1  μg)  was  performed  using 
ImProm-II  (Promega,  Madison,  WI,  U.S.)  and  Oligo(dT)15  primers  (Promega).  The  primers  used  to 
amplify the human IL-6 complementary DNA (cDNA) were 5’-CCACTCACCTCTTCAGAACGAA-3’ 
(sense)  and  5’-GGCAAGTCTCCTCATTGAATCC-3’  (antisense),  and  those  used  to  amplify  
the  internal  control  cDNA,  glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH),  were  
5’-TGGTATCGTGGAAGGACTCATGAC-3’ (sense) and 5’-ATGCCAGTGAGCTTCCCGTTCAGC-3’ 
(antisense).  Quantitative  real-time  reverse  transcription  polymerase  chain  reaction  (RT-PCR)  was 
performed on a Light-Cycler instrument (Roche Diagnostics, Indianapolis, IN, U.S.) according to the 
manufacturer’s instructions with FastStart DNA Master SYBR Green I reagent (Roche Diagnostics). 
Each sample was determined in triplicate and the results for IL-6 were normalized to the level of 
GAPDH mRNA. On the other hand, aliquots of the supernatant were collected to measure the IL-6 
levels. The release of IL-6 from cultivated cells into the conditioned medium was detected by the 
Quantikine enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, U.S.) 
specific  for  human  IL-6.  Cytokine  bioassays  were  performed  according  to  the  manufacturer’s 
instructions.  Photometric  readings  at  450  nm  were  measured  using  the  Spectrophotometer 
(ThermoLabsystems,  Vantaa,  Finland).  Results  were  expressed  as  pg/mL.  All  experiments  were 
conducted in quadruplicate. 
3.6. Apoptosis Assays 
After seeding overnight, the attached RPE cells were exposed to various chitosan membranes for  
24  h.  Apoptotic  cells  in  ARPE-19  cultures  were  determined  using  a  terminal  deoxynucleotidyl 
transferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay (Roche Diagnostics). Samples 
were fixed with 4% paraformaldehyde for 1 h at room temperature. After washing with PBS, the fixed 
specimens were permeabilized in 0.1% Triton X-100 in 0.1% sodium citrate for 2 min on ice and 
incubated with a mixture of TdT solution and fluorescein isothiocyanate dUTP solution in a humidified 
chamber for 1 h at 37 °C . The negative controls were incubated with distilled water in place of TdT 
enzyme. Cells treated with DNase served as positive controls. To visualize cell nuclei, the samples 
were  stained  with  4’,6-diamidino-2-phenylindole  (DAPI;  Vector,  Peterborough,  England)  and 
examined microscopically at 400×  magnification. Ten different areas were randomly selected, and the 
number of TUNEL-positive cell nuclei was quantified. All experiments were conducted in triplicate, 
and the apoptotic index was calculated as the average ratio of apoptotic cells to the total number of 
cells in these 30 different areas. Int. J. Mol. Sci. 2010, 11                       
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3.7. Statistics 
Results  were  expressed  as  mean  ±   standard  deviation.  Comparative  studies  of  means  were 
performed using one-way analysis of variance (ANOVA). Significance was accepted with p < 0.05. 
4. Conclusions 
In  this  work,  cell  viability  assays,  cytokine  expression  analyses,  and  apoptosis  assays  were 
performed to examine the interaction between human RPE cells and various chitosan materials. The 
biocompatibility of non-cross-linked chitosan membranes is demonstrated by the absence of any signs 
of toxicity or inflammation reaction. We have also investigated the effect of cross-linker functionality 
on the in vitro cellular responses to chemically modified chitosan samples. The results suggest that 
while the chitosan molecules bridged by GP are satisfactorily cytocompatible, the counterparts treated 
by GTA do not seem to be tolerated. In terms of material safety, the GP cross-linked chitosan may have 
biocompatibility  for  potential  application  as  delivery  carrier  in  the  treatment  of  posterior  
segment diseases. 
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